Dyne Therapeutics, Inc. (DYN)
16.61
+0.89
(+5.66%)
USD |
NASDAQ |
Oct 27, 10:42
Dyne Therapeutics Price to Book Value : 3.919 for Oct. 27, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 3.709 |
| October 23, 2026 | 3.686 |
| October 22, 2026 | 3.721 |
| October 21, 2026 | 3.792 |
| October 20, 2026 | 3.839 |
| October 19, 2026 | 3.594 |
| October 16, 2026 | 3.362 |
| October 15, 2026 | 3.608 |
| October 14, 2026 | 3.549 |
| October 13, 2026 | 3.61 |
| October 12, 2026 | 3.766 |
| October 09, 2026 | 3.926 |
| October 08, 2026 | 3.862 |
| October 07, 2026 | 3.768 |
| October 06, 2026 | 3.634 |
| October 05, 2026 | 3.643 |
| October 02, 2026 | 3.586 |
| October 01, 2026 | 3.733 |
| September 30, 2026 | 3.801 |
| September 29, 2026 | 3.825 |
| September 28, 2026 | 3.855 |
| September 25, 2026 | 3.782 |
| September 24, 2026 | 3.896 |
| September 23, 2026 | 3.829 |
| September 22, 2026 | 4.044 |
| Date | Value |
|---|---|
| September 21, 2026 | 4.039 |
| September 18, 2026 | 4.037 |
| September 17, 2026 | 4.261 |
| September 16, 2026 | 4.083 |
| September 15, 2026 | 4.224 |
| September 14, 2026 | 4.370 |
| September 11, 2026 | 4.297 |
| September 10, 2026 | 4.346 |
| September 09, 2026 | 4.528 |
| September 08, 2026 | 4.792 |
| September 04, 2026 | 5.729 |
| September 03, 2026 | 5.887 |
| September 02, 2026 | 5.932 |
| September 01, 2026 | 5.922 |
| August 31, 2026 | 6.000 |
| August 28, 2026 | 5.915 |
| August 27, 2026 | 6.156 |
| August 26, 2026 | 6.220 |
| August 25, 2026 | 6.215 |
| August 24, 2026 | 6.132 |
| August 21, 2026 | 6.158 |
| August 20, 2026 | 6.130 |
| August 19, 2026 | 6.319 |
| August 18, 2026 | 6.135 |
| August 17, 2026 | 6.17 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.63 |
| Anika Therapeutics, Inc. | 2.085 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.112 |
Price to Book Value Related Metrics
| Price | 16.61 |
| Earnings Yield | -20.06% |
| Market Cap | 2.752B |